Name: aida santaolalla

Country: United Kingdom


Kings College London

Email: Send an Email


Research Oncology, Guy's Hospital London SE1 9RT, United Kingdom

Research Interests:

Exposure assessment Biomarkers early detection new statistical methods



  1. King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB).
  2. Use of a handheld terahertz pulsed imaging device to differentiate benign and malignant breast tissue.
  3. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure.
  4. Mutation of duffy antigen receptor for chemokines (DARC) as an indicator of prostate cancer severity in Afro-Caribbean men.
  5. Real World Evidence: A Quantitative and Qualitative Glance at Participant Feedback from a Free-Response Survey Investigating Experiences of a Structured Exercise Intervention for Men with Prostate Cancer.
  6. Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer.
  7. The use of Latent Class Analysis to predict cancer risk based on a panel of serum biomarkers in the Swedish AMORIS study.
  8. The use of a handheld Terahertz pulsed imaging device to differentiate benign and malignant breast tissue with a view to reducing re-operation rates in breast-conserving surgery.
  9. Metabolic serum biomarkers for the prediction of cancer: A follow-up of the studies conducted in the Swedish AMORIS study.
  10. Role of serum lipids and glucose as biomarkers of prostate cancer severity..
  11. Radical prostatectomy follow up in secondary care - how long is too long?